Indraprastha Medical Corporation
406.45
-0.55(-0.14%)
Market Cap₹3,726.05 Cr
PE Ratio20.37
Company Performance:
1D-0.14%
1M+10.12%
6M-26.04%
1Y-4.35%
5Y+598.97%
View Company Insightsright
More news about Indraprastha Medical Corporation
01Nov 25
Indraprastha Medical Corp Reports Revenue Growth to Rs 3.8B in Q2
Indraprastha Medical Corporation Limited, operating Indraprastha Apollo Hospitals, has reported significant financial growth in Q2. Revenue increased to ₹3.80 billion from ₹3.50 billion year-over-year. EBITDA rose to ₹713.00 million from ₹636.00 million, with an improved EBITDA margin of 18.72%. Net profit grew by 16.60% to ₹494.60 crore. The company's Board of Directors approved these unaudited financial results in a recent meeting.
 no imag found
08Oct 25
Indraprastha Medical Shares Soar to All-Time High on CGHS Tariff Revision
Indraprastha Medical Corporation's shares have reached an all-time high of Rs 624.00, driven by a significant revision in Central Government Health Services (CGHS) tariffs. The stock has gained over 30% in 2 days, nearly 40% in 5 days, and 44% over the past 12 months. The CGHS has announced its largest tariff revision in 15 years, increasing rates by 5-30% for nearly 2,000 medical procedures. This is expected to positively impact the company's financials, particularly in specialties like Orthopaedics, Cardiology, and Oncology. However, the stock's RSI of 82.00 suggests potential overbought conditions.
 no imag found
06Aug 25
Indraprastha Medical Corp Reports Robust Q1 Performance with 15% Net Profit Growth
Indraprastha Medical Corporation Limited, operating as Indraprastha Apollo Hospitals, announced robust Q1 results. EBITDA increased to ₹726.00 million from ₹680.00 million year-over-year, with EBITDA margin rising to 19.89%. Net profit grew by 15% to ₹515.00 million, and revenue rose to ₹3.70 billion. The company reported a 4.94% increase in revenue from operations and a 14.94% increase in profit after tax. The Board of Directors made key corporate governance decisions, including new appointments and scheduling the 37th Annual General Meeting.
 no imag found
16May 25
Indraprastha Medical Corp Reports Strong Q4 Results, Declares Dividend
Indraprastha Medical Corp announced impressive Q4 financial results with EBITDA rising to ₹615.00 million from ₹484.00 million year-over-year. Net profit increased to ₹410.00 million, up 31.41% YoY. Revenue grew by 5.10% to ₹3.30 billion. The company declared a dividend of ₹4.50 per equity share. Annual performance showed significant growth with revenue up 13.79%, EBITDA up 30.80%, and net profit up 44.02% YoY. EPS increased from ₹9.40 to ₹13.52, and operating profit margin improved to 15.53% from 13.72%.
 no imag found
1 Year Returns:-4.35%
Industry Peers
Apollo Hospitals
7,732.50
(-0.62%)
Fortis Healthcare
929.30
(+0.28%)
Aster DM Healthcare
705.25
(+2.57%)
Narayana Hrudayalaya
1,768.30
(-1.65%)
Global Health
1,105.55
(-0.52%)
Park Medi World
232.70
(+1.69%)